Ibayashi Y, Hoon D S, Golub S H
Department of Surgery, UCLA School of Medicine 90024-1781.
Cell Immunol. 1987 Dec;110(2):365-78. doi: 10.1016/0008-8749(87)90129-8.
We analyzed the effect of adherent cells on the induction of lymphokine-activated killer (LAK) cell activity by depleting adherent cells from peripheral blood lymphocytes (PBL) or by adding adherent cells to PBL before culture with interleukin-2. We found that adherent cells clearly down-regulate LAK cell induction. These inhibitory effects are dependent on the number of adherent cells added. Inhibitory effects of adherent cells are abolished by the addition of indomethacin to the LAK culture. Soluble factors derived from adherent cells, such as interferons and interleukin-1, have a slight enhancing effect on LAK induction. In contrast, adherent cells appear to inhibit LAK induction primarily by producing prostaglandin E2(PGE2). PGE2 in turn inhibits the induction of LAK effector cells by inhibiting the expression of the transferrin receptor on LAK cells. These effects are manifested most strikingly in the early phases of LAK induction.
我们通过从外周血淋巴细胞(PBL)中去除贴壁细胞,或在与白细胞介素-2共同培养前向PBL中添加贴壁细胞,分析了贴壁细胞对淋巴因子激活的杀伤(LAK)细胞活性诱导的影响。我们发现贴壁细胞明显下调LAK细胞的诱导。这些抑制作用取决于添加的贴壁细胞数量。向LAK培养物中添加消炎痛可消除贴壁细胞的抑制作用。来自贴壁细胞的可溶性因子,如干扰素和白细胞介素-1,对LAK诱导有轻微的增强作用。相反,贴壁细胞似乎主要通过产生前列腺素E2(PGE2)来抑制LAK诱导。PGE2反过来通过抑制LAK细胞上转铁蛋白受体的表达来抑制LAK效应细胞的诱导。这些效应在LAK诱导的早期阶段最为明显。